Tuhina Neogi, MD, PhD Associate Professor of Medicine and Epidemiology Boston University School of Medicine Boston, MA
Naomi Amudala, MSN, RN, FNP-BC Clinical Instructor and Nurse Practitioner Vasculitis Center/Rheumatology Boston University School of Medicine Boston, MA
AMA PRA Category 1 Credit TM
The goal of this interactive newsletter is to expand the ability of physicians and other clinicians to implement best practices in the management of RA based on the latest clinical evidence. RA currently affects approximately 1.3 million people in the United States. Early treatment initiation, ongoing monitoring of therapeutic response, and appropriate treatment adjustments are critical to improving patient outcomes. This activity will review new treatment guidelines and evolving data that may help clinicians improve outcomes for their patients.
This activity is co-provided by The University of Chicago Pritzker School of Medicine and MCM Education.
This activity is intended for physicians, PAs, and NPs interested in rheumatology.
Upon completion of this educational activity, the participant should be able to:
Initiate early treatment of RA with DMARDs where appropriate according to treatment guidelines.
Adjust RA treatment regimens as needed to achieve established treatment targets.
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational activities. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and the credit providers have a process in place to resolve any conflict of interest.
Tuhina Neogi, MD, PhD, has nothing to disclose.
Naomi Amudala, MSN, RN, FNP-BC, has nothing to disclose.
The University of Chicago Pritzker School of Medicine staff involved in the development and review of this activity have nothing to disclose.
Anne Jacobson, MCM Medical Writer, has nothing to disclose.
Kathleen Hines, MCM Education Editorial Director, has nothing to disclose.
Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit is awarded to participants who score 80% or better on the post-test.
The online activity will take approximately 30 minutes to complete. Commercial Support Statements
Supported by independent educational grants from AbbVie, Inc. and Lilly.
Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
There are no fees for participating in or receiving credit for this online educational activity. This activity is designed to be completed within the time designated on this page; physicians should claim only those credits that reflect the time actually spent in the activity.
Review the intended audience, learning objectives, and author disclosures.
Study the educational content online.
Once completed, continue to post-test. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. In addition, you must also complete the Activity Evaluation.
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, The University of Chicago Pritzker School of Medicine, AbbVie, or Lilly. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.